Follow the Novacyt S.A. share price and the full directors' dealings record of the company, a listed issuer based in United Kingdom. Shares trade on the UK market, under the supervision of RNS (LSE). Market capitalisation: €27.1m. The latest transaction was filed on 30 March 2026 (Purchase). Among the most active insiders: 1) CEO 2) Chairman 3) NED. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Novacyt S.A. 是一家生物技术公司,专注于开发传染病诊断测试。该公司在伦敦市场上市,股票代码为 XLON。